Mr Hemal Mehta

Job title

Consultant ophthalmic surgeon

Qualifications

MBBS (London) MA (Cantab.) FRCOphth

GMC Number

6129790

Contact details

PA/secretary phone number: 020 8216 4502

Private practice phone number: 07566 223 705

Related services

Ophthalmology

Biography

Mr Hemal Mehta is a consultant ophthalmic surgeon who specialises in medical retinal conditions (e.g. age-related macular degeneration and diabetic retinopathy) and cataract surgery and is leading the expansion of the ophthalmology department's clinical trials unit at the Barnet Hospital. 

Research website: www.researchgate.net/profile/Hemal_Mehta2 

Publications

  • Leah KN, Mehta H, Barthelmes D & Gillies MC. Meta-analysis of real world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina. (2016)
  • Fraser-Bell S, Lim LL, Campain A, Mehta H, Aroney C, Bryant J, Li J, Quin GJ, MCallister IL & Gillies MC. Bevacizumab or dexamethasone implants for diabetic macular edema: 2-year results (The BEVORDEX Study). Ophthalmology. (2016)
  • Mehta H, Gillies MC & Fraser-Bell S. Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema. Clinical & Experimental Ophthalmology. (2016) 
  • Pakzad-Vaezi K, Mehta H, Mammo Z & Tufail A. Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia. Expert Opinion on Biological Therapies. (2016)
  • Mehta H, Fraser-Bell S, Campain A & Gillies MC. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema (Protocol). Cochrane Database of Systematic Reviews, Issue 3. (2015)
  • Gillies MC, Mehta H & Bird AC. Macular telangiectasia type 2 without clinically detectable vasculopathy. JAMA Ophthalmology. (2015)
  • Mehta H, Fraser-Bell S, Yeung A., Campain A., Lim LL, Quin GJ, MCallister IL, Keane PA & Gillies MC. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial. British Journal of Ophthalmology. (2015)
  • Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, Fruttiger M., Egan CA & Tufail A. Re-evaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. American Journal of Ophthalmology. (2015)
  • Mehta H, Gillies MC & Fraser-Bell S. Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema. Therapeutic Advances in Chronic Disease. (2015)
  • Mehta H, Sim DA, Keane PA, Zarranz-Ventura J, Gallagher K, Egan CA, Westcott M, Lee RW, Tufail A & Pavesio CE. Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis. Eye (London). (2015)